Remarkable changes are occurring across the spectrum of orthopedic care, including an acceleration of the movement of procedures from traditional inpatient settings to ambulatory settings. Forward-thinking orthopedic companies will invest strategic and tactical resources to understand, predict and capitalize on these changes.
This keynote brings together the device company, surgeon and healthcare intelligence perspectives to share when and where the shift will occur, surgeon needs in the outpatient setting and insight into how device companies are responding.
Patrick Vega, Consulting Director, Vizient Advisory Solutions
Mr. Vega consults to member hospitals, health systems and physicians in musculoskeletal services with a focus on high-value care by aligning cost, quality and performance. He has used his unique combination of breadth and depth of healthcare industry knowledge to deliver business development successes for hospitals, healthcare organizations, medical device companies and physician practices.
Robert S. Bray, Spine Surgeon and Founding Director and CEO of DISC Sports & Spine Center
Dr. Bray makes an art of helping the world’s most elite athletes return to push the boundaries of performance. He is widely recognized as the pioneer of modern day spine surgery. With over 28 years in private practice, he has performed over 13,000+ successful procedures and holds over 25 patents on the techniques and instruments used worldwide.
Laura Rector, Vice President, Ambulatory Surgery Center Strategy & Development, Smith+Nephew
Laura Rector is dedicated to helping patients benefit from top-quality brands by optimizing brand access, awareness, loyalty, value-based pricing and global commercial launch success. Throughout her career, she has successfully devised and implemented transformational strategies while minimizing operational expenses, improving enterprise processes and building best-in-class teams across a wide variety of marketing disciplines.
Ryota Terada, Director, Orthopedics and Payment & Policy, Sg2 Health Care Intelligence
As a member of Sg2’s Intelligence team, Mr. Terada contributes to the development and delivery of orthopedics and spine offerings. He contributes to publications, web seminars, the annual development of Sg2’s Impact of Change forecast and other analytical tools. In his time at Sg2, Ryota has also focused on payment- and policy-related topics, including alternative payment models, site-neutral payment, and MACRA.
Kate Zentner, Director, Neuroscience Intelligence, Sg2 Health Care Intelligence
Ms. Zentner leads the development and delivery of Sg2’s neurosciences, spine and orthopedics offerings. In her current role, she has contributed to projects including the annual development of Sg2’s Impact of Change® forecast, numerous white papers and service line–focused consulting engagements, and is a national speaker. Prior to joining Sg2, Kate worked at Rush University Medical Center in emergency management.